111

KONTAFARMA CHINA HOLDINGS LTD

No trades
See on Supercharts
Market capitalization
‪189.68 M‬HKD
−0.005HKD
‪−28.84 M‬HKD
‪809.11 M‬HKD
‪1.90 B‬
Beta (1Y)
0.13

About KONTAFARMA CHINA HOLDINGS LTD

CEO
Chao Wen Jiang
Headquarters
Hong Kong
Employees (FY)
720
Founded
2011
ISIN
KYG8918D1088
FIGI
BBG002CVBKN1
Kontafarma China Holdings Ltd. engages in the manufacture and sale of cement. It operates through the following segments: Pharmaceutical and Fitness Business. The Pharmaceutical Business segment involves in manufacture and sales of prescription drugs and laboratory related products. The Fitness Business segment includes the operation of fitness centers and provide consultation services for fitness and health activities and operate the franchise business for royalty fee income. The company was founded on March 21, 2011 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1312 is 0.034 HKD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange KONTAFARMA CHINA HOLDINGS LTD stocks are traded under the ticker 1312.
1312 stock is 0% volatile and has beta coefficient of 0.13. Check out the list of the most volatile stocks — is KONTAFARMA CHINA HOLDINGS LTD there?
Yes, you can track KONTAFARMA CHINA HOLDINGS LTD financials in yearly and quarterly reports right on TradingView.
1312 stock has fallen by 2.86% compared to the previous week, the month change is a 3.03% rise, over the last year KONTAFARMA CHINA HOLDINGS LTD has showed a 24.44% decrease.
1312 net income for the last quarter is ‪−67.98 M‬ HKD, while the quarter before that showed ‪39.14 M‬ HKD of net income which accounts for −273.70% change. Track more KONTAFARMA CHINA HOLDINGS LTD financial stats to get the full picture.
No, 1312 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1312 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KONTAFARMA CHINA HOLDINGS LTD stock right from TradingView charts — choose your broker and connect to your account.
1312 reached its all-time high on Jun 1, 2015 with the price of 2.030 HKD, and its all-time low was 0.026 HKD and was reached on Oct 14, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 720.00 employees. See our rating of the largest employees — is KONTAFARMA CHINA HOLDINGS LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KONTAFARMA CHINA HOLDINGS LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KONTAFARMA CHINA HOLDINGS LTD stock shows the sell signal. See more of KONTAFARMA CHINA HOLDINGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KONTAFARMA CHINA HOLDINGS LTD EBITDA is ‪−59.00 M‬ HKD, and current EBITDA margin is −7.29%. See more stats in KONTAFARMA CHINA HOLDINGS LTD financial statements.